[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Novel Oral AntiCoagulants (NOAC) Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

June 2019 | 77 pages | ID: N90B281A060EN
99Strategy

US$ 2,280.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to 99Strategy, the Global Novel Oral AntiCoagulants (NOAC) Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Novel Oral AntiCoagulants (NOAC) market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions
  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
Key Companies
  • Johnson & Johnson
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Sanofi
  • Daiichi Sankyo
  • Armatheon
  • Aspen
  • AstraZeneca
  • Bayer
  • Cellceutix
  • Cosmo Pharmaceuticals
  • CSL Behring
  • Eisai
  • GSK
  • Marathon Pharmaceuticals
  • Ockham Biotech
  • Perosphere
Key Product Type
  • Direct Thrombin Inhibitors
  • Direct Factor Xa Inhibitors
Market by Application
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism
  • Acute Coronary Syndrome
  • Hemodialysis
  • Others
Main Aspects covered in the Report
  • Overview of the Novel Oral AntiCoagulants (NOAC) market including production, consumption, status & forecast and market growth
  • 2015-2018 historical data and 2019-2025 market forecast
  • Geographical analysis including major countries
  • Overview the product type market including development
  • Overview the end-user market including development
1 INDUSTRIAL CHAIN OVERVIEW

1.1 Novel Oral AntiCoagulants (NOAC) Industry
  1.1.1 Overview
  1.1.2 Characteristics of Novel Oral AntiCoagulants (NOAC)
1.2 Upstream
  1.2.1 Major Materials
  1.2.2 Manufacturing Overview
1.3 Product List By Type
  1.3.1 Direct Thrombin Inhibitors
  1.3.2 Direct Factor Xa Inhibitors
1.4 End-Use List
  1.4.1 Demand in Deep Vein Thrombosis (DVT)
  1.4.2 Demand in Pulmonary Embolism
  1.4.3 Demand in Acute Coronary Syndrome
  1.4.4 Demand in Hemodialysis
  1.4.5 Demand in Others
1.5 Global Market Overview
  1.5.1 Global Market Size and Forecast, 2015-2025
  1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
  1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
  1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 GLOBAL PRODUCTION & CONSUMPTION BY GEOGRAPHY

2.1 Global Production & Consumption
  2.1.1 Global Production
  2.1.2 Global Consumption
2.2 Geographic Production & Consumption
  2.2.1 Production
    2.2.1.1 Asia-Pacific
    2.2.1.2 North America
    2.2.1.3 South America
    2.2.1.4 Europe
    2.2.1.5 Middle East & Africa
  2.2.2 Consumption
    2.2.2.1 Asia-Pacific
    2.2.2.2 North America
    2.2.2.3 South America
    2.2.2.4 Europe
    2.2.2.5 Middle East & Africa

3 MAJOR MANUFACTURERS INTRODUCTION

3.1 Manufacturers Overview
3.2 Manufacturers List
  3.2.1 Johnson & Johnson Overview
    3.2.1.1 Product Specifications
    3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.1.3 Recent Developments
    3.2.1.4 Future Strategic Planning
  3.2.2 Bristol-Myers Squibb Overview
    3.2.2.1 Product Specifications
    3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.2.3 Recent Developments
    3.2.2.4 Future Strategic Planning
  3.2.3 Boehringer Ingelheim Overview
    3.2.3.1 Product Specifications
    3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.3.3 Recent Developments
    3.2.3.4 Future Strategic Planning
  3.2.4 Sanofi Overview
    3.2.4.1 Product Specifications
    3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.4.3 Recent Developments
    3.2.4.4 Future Strategic Planning
  3.2.5 Daiichi Sankyo Overview
    3.2.5.1 Product Specifications
    3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.5.3 Recent Developments
    3.2.5.4 Future Strategic Planning
  3.2.6 Armatheon Overview
    3.2.6.1 Product Specifications
    3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.6.3 Recent Developments
    3.2.6.4 Future Strategic Planning
  3.2.7 Aspen Overview
    3.2.7.1 Product Specifications
    3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.7.3 Recent Developments
    3.2.7.4 Future Strategic Planning
  3.2.8 AstraZeneca Overview
    3.2.8.1 Product Specifications
    3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.8.3 Recent Developments
    3.2.8.4 Future Strategic Planning
  3.2.9 Bayer Overview
    3.2.9.1 Product Specifications
    3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.9.3 Recent Developments
    3.2.9.4 Future Strategic Planning
  3.2.10 Cellceutix Overview
    3.2.10.1 Product Specifications
    3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.10.3 Recent Developments
    3.2.10.4 Future Strategic Planning
  3.2.11 Cosmo Pharmaceuticals Overview
    3.2.11.1 Product Specifications
    3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.11.3 Recent Developments
    3.2.11.4 Future Strategic Planning
  3.2.12 CSL Behring Overview
    3.2.12.1 Product Specifications
    3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.12.3 Recent Developments
    3.2.12.4 Future Strategic Planning
  3.2.13 Eisai Overview
    3.2.13.1 Product Specifications
    3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.13.3 Recent Developments
    3.2.13.4 Future Strategic Planning
  3.2.14 GSK Overview
    3.2.14.1 Product Specifications
    3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.14.3 Recent Developments
    3.2.14.4 Future Strategic Planning
  3.2.15 Marathon Pharmaceuticals Overview
    3.2.15.1 Product Specifications
    3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.15.3 Recent Developments
    3.2.15.4 Future Strategic Planning
  3.2.16 Ockham Biotech Overview
    3.2.16.1 Product Specifications
    3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.16.3 Recent Developments
    3.2.16.4 Future Strategic Planning
  3.2.17 Perosphere Overview
    3.2.17.1 Product Specifications
    3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
    3.2.17.3 Recent Developments
    3.2.17.4 Future Strategic Planning

4 MARKET COMPETITION PATTERN

4.1 Market Size and Sketch
4.2 Company Market Share
  4.2.1 Global Production by Major Manufacturers
  4.2.2 Market Concentration Analysis
4.3 Market News and Trend
  4.3.1 Merger & Acquisition
  4.3.2 New Product Launch

5 PRODUCT TYPE SEGMENT

5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Product Type
  5.2.1 Market in Direct Thrombin Inhibitors
    5.2.1.1 Market Size
    5.2.1.2 Situation & Development
  5.2.2 Market in Direct Factor Xa Inhibitors
    5.2.2.1 Market Size
    5.2.2.2 Situation & Development

6 END-USE SEGMENT

6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
  6.2.1 Market in Deep Vein Thrombosis (DVT)
    6.2.1.1 Market Size
    6.2.1.2 Situation & Development
  6.2.2 Market in Pulmonary Embolism
    6.2.2.1 Market Size
    6.2.2.2 Situation & Development
  6.2.3 Market in Acute Coronary Syndrome
    6.2.3.1 Market Size
    6.2.3.2 Situation & Development
  6.2.4 Market in Hemodialysis
    6.2.4.1 Market Size
    6.2.4.2 Situation & Development
  6.2.5 Market in Others
    6.2.5.1 Market Size
    6.2.5.2 Situation & Development

7 MARKET FORECAST & TREND

7.1 Regional Forecast
7.2 Consumption Forecast
  7.2.1 Product Type Forecast
  7.2.2 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend

8 PRICE & CHANNEL

8.1 Price and Cost
  8.1.1 Price
  8.1.2 Cost
8.2 Channel Segment

9 MARKET DRIVERS & INVESTMENT ENVIRONMENT

9.1 Market Drivers
9.2 Investment Environment

10 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Johnson & Johnson Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Daiichi Sankyo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Armatheon Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Armatheon (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Aspen Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Aspen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bayer Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Bayer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cellceutix Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Cellceutix (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Cosmo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table CSL Behring Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of CSL Behring (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Eisai Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Eisai (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table GSK Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of GSK (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Marathon Pharmaceuticals Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Marathon Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Ockham Biotech Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Ockham Biotech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Perosphere Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Perosphere (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume

LIST OF FIGURES

Figure Novel Oral AntiCoagulants (NOAC) Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Direct Thrombin Inhibitors, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Direct Thrombin Inhibitors, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Direct Factor Xa Inhibitors, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Direct Factor Xa Inhibitors, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Deep Vein Thrombosis (DVT), 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Deep Vein Thrombosis (DVT), 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Pulmonary Embolism, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Pulmonary Embolism, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Acute Coronary Syndrome, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Acute Coronary Syndrome, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hemodialysis, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hemodialysis, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume


More Publications